• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

5AM Ventures

edit

5AM Ventures is a seed and early-stage venture capital firm focused on building next-generation life science companies. Founded in 2002, 5AM Ventures has over $200 million under management and is actively investing its second fund. The firm has offices in Menlo Park, CA and Waltham, MA.

Recent Milestones

edit

• 
  5AM Ventures invested in Ceterix Orthopaedics. (1/23/13)
  Posted 1/22/13 at 8:58pm via finsmes.com
• 
  5AM Ventures invested in Flexion Therapeutics. (12/4/12)
  Posted 12/4/12 at 7:39pm via reuters.com
• 
  5AM Ventures invested in Pearl Therapeutics. (11/13/12)
  Posted 11/14/12 at 7:01pm via finsmes.com
• 
  5AM Ventures invested in Novira Therapeutics. (8/24/12)
  Posted 8/24/12 at 4:53am via finsmes.com
• 
  5AM Ventures invested in Atterocor. (8/3/12)
  Posted 8/3/12 at 7:34pm via finsmes.com
• 
  5AM Ventures invested in Igenica. (6/12/12)
  Posted 6/12/12 at 6:45pm via finsmes.com
• 
  5AM Ventures invested in Cleave Biosciences. (10/11/11)
  Posted 10/11/11 at 7:32pm via finsmes.com
• 
  5AM Ventures invested in Pulmatrix. (8/15/11)
  Posted 8/15/11 at 4:07am via businesswire.com
• 
  5AM Ventures invested in DVS Sciences. (7/14/11)
  Posted 7/14/11 at 5:47pm via finsmes.com
• 
  5AM Ventures invested in Semprus BioSciences. (12/13/10)
  Posted 12/13/10 at 6:36pm via semprusbio.com
• 
  5AM Ventures invested in Pearl Therapeutics. (10/19/10)
  Posted 10/19/10 at 8:59pm via fiercebiotech.com
• 
  5AM Ventures invested in Synosia Therapeutics. (10/12/10)
  Posted 10/20/10 at 10:55pm via synosia.com
• 
  5AM Ventures invested in Relypsa. (9/13/10)
  Posted 9/14/10 at 5:39pm via finsmes.com
• 
  5AM Ventures invested in Incline Therapeutics. (6/28/10)
  Posted 6/28/10 at 5:21pm via onbiovc.com
• 
  5AM Ventures invested in Igenica. (6/14/10)
  Posted 6/14/10 at 6:53pm via onbiovc.com
• 
  5AM Ventures invested in Achaogen. (4/7/10)
  Posted 4/7/10 at 8:27pm via pr-inside.com

Investments

Videos

Sources

1. SEC (sec.gov) [edit]
2. AltAssets (altassets.com) [edit]
3. AltAssets (altassets.com) [edit]
4. SEC D (sec.gov) [edit]
5. SEC D/A (sec.gov) [edit]
6. Ceterix Orthopaedics Raises $19.5M in Series B Financing (finsmes.com) [edit]
7. Flexion Therapeutics Secures $20 Million in Series B Financing (reuters.com) [edit]
8. Pearl Therapeutics Raises $65M in Series D Financing (finsmes.com) [edit]
9. Novira Therapeutics Secures $23M in Series A Financing (finsmes.com) [edit]
10. Atterocor Raises $16M in Series A Funding (finsmes.com) [edit]
11. Igenica Raises $33M in Series C Funding (finsmes.com) [edit]
12. Cleave Biosciences Raises $42M in Series A Financing (finsmes.com) [edit]
13. Pulmatrix Secures a $14 million Financing to Advance Clinical Programs in COPD and Cystic Fibrosis (eon.businesswire.com) [edit]
14. DVS Sciences Completes $14.6M Series A Financing (finsmes.com) [edit]
15. SEMPRUS BIOSCIENCES RAISES ADDITIONAL $18 MILLION (semprusbio.com) [edit]
16. Pearl lands $69M Series C for mid-stage COPD program (fiercebiotech.com) [edit]
17. Synosia Therapeutics Raises $30M in Series C Financing (synosia.com) [edit]
18. Relypsa Raises $70M in Series B Financing (finsmes.com) [edit]
19. Incline Therapeutics, Inc.: Series A $43M (onbiovc.com) [edit]
20. Igenica, Inc.: Series B $24M (onbiovc.com) [edit]
21. Achaogen Completes $56 Million Series C Financing (pr-inside.com) [edit]
22. Pearl Therapeutics, Inc.: Series C $15M (onbiovc.com) [edit]
23. Xconomy Boston (xconomy.com) [edit]
24. Flexion garners $33M in Series A (fiercebiotech.com) [edit]
25. Rennovia Grabs $12M for Renewable Chemicals (earth2tech.com) [edit]
26. Anaphore, Inc.: Series A $13M (onbiovc.com) [edit]
27. Ambrx, Inc.: Series D $10M (onbiovc.com) [edit]
28. Mass High Tech (masshightech.com) [edit]
29. Synosia raises $29M for Phase II testing (fiercebiotech.com) [edit]
30. KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million (kalobios.com) [edit]
31. Semrus BioSciences Raises $8 Million (us.ellre.com) [edit]
32. Capital Report Index [edit]
33. Pearl Therapeutics ups its first round funding (deals.venturebeat.com) [edit]
34. April 15, 2008 - Anaphore Receives $8M In Financing (anaphoreinc.com) [edit]
35. Biotech Startup PhaseRx Wins $19M Pledge (biospace.com) [edit]
36. 5AM Ventures puts $3.3M into stealthy immunology startup ImmunoNewco (deals.venturebeat.com) [edit]
37. Amgen, Relypsa and the art of the biotech-spinout-startup-restart (venturebeat.com) [edit]
38. MARCADIA BIOTECH COMPLETES $15 MILLION SERIES A FINANCING (marcadiabiotech.com) [edit]
39. Neurological co. Synosis raises $32.5M (deals.venturebeat.com) [edit]
40. Variation Biotechnologies Secures US$35.7 Million in Series A Financing to Fund Innovative Vaccine Platform (variationbiotech.com) [edit]
41. Achaogen Closes Series B Financing (achaogen.com) [edit]
42. EDGAR [edit]